{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:23:45Z","timestamp":1793413425426,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220565"],"award-info":[{"award-number":["220565"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115910"],"award-info":[{"award-number":["115910"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.lanmic.2025.101219","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:40:26Z","timestamp":1767829226000},"page":"101219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mucosal immune responses to Bordetella pertussis in Gambian infants after maternal and primary vaccination: an immunological substudy of a single-centre, randomised, controlled, double-blind, phase 4 trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Anja","family":"Saso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1487-3633","authenticated-orcid":false,"given":"Janeri","family":"Fr\u00f6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haddijatou","family":"Jobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Eleveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Okoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrima","family":"Kanteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1110-3968","authenticated-orcid":false,"given":"Annemijn","family":"Arns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"van Opzeeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kumado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8836-9985","authenticated-orcid":false,"given":"Amadou","family":"Faal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elishia","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modou-Lamin","family":"Fofana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aru-Kumba","family":"Baldeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karamo","family":"Conteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"van Cranenbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Roetynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marien","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thushan I","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Huynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7065-7807","authenticated-orcid":false,"given":"Dimitri A","family":"Diavatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2025.101219_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41579-024-01064-8","article-title":"Pertussis vaccines, epidemiology and evolution","volume":"22","author":"Domenech de Cell\u00e8s","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.lanmic.2025.101219_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lanmic.2025.101219_bib5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa050824","article-title":"Efficacy of an acellular pertussis vaccine among adolescents and adults","volume":"353","author":"Ward","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2025.101219_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/vaccines8040695","article-title":"Acellular pertussis vaccine inhibits Bordetella pertussis clearance from the nasal mucosa of mice","volume":"8","author":"Holubov\u00e1","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.lanmic.2025.101219_bib7","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3389\/fimmu.2018.03068","article-title":"The role of mucosal immunity in pertussis","volume":"9","author":"Solans","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanmic.2025.101219_bib8","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.12688\/f1000research.11654.1","article-title":"The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis","volume":"6","author":"Gill","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.lanmic.2025.101219_bib9","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","article-title":"Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels","volume":"182","author":"Jaffar","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.lanmic.2025.101219_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102355","article-title":"Nasal vaccines for pertussis","volume":"84","author":"Schmitt","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.lanmic.2025.101219_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/cid\/civ472","article-title":"Risk factors associated with infant deaths from pertussis: a case\u2013control study","volume":"61","author":"Winter","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101219_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/infdis\/jiab325","article-title":"Pertussis toxin promotes pulmonary hypertension in an infant mouse model of Bordetella pertussis infection","volume":"225","author":"Scanlon","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101219_bib13","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2025.101219_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101219_bib15","doi-asserted-by":"crossref","first-page":"e1087","DOI":"10.1093\/cid\/ciac432","article-title":"Maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination during pregnancy: impact on infant anti-pertussis antibody concentrations by maternal pertussis priming series","volume":"76","author":"Havers","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101219_bib16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41467-024-44943-7","article-title":"Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study","volume":"15","author":"Briga","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanmic.2025.101219_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eclinm.2019.06.010","article-title":"The effect of maternal immunisation during pregnancy on infant vaccine responses","volume":"13","author":"Zimmermann","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.lanmic.2025.101219_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.12688\/wellcomeopenres.22398.1","volume":"9","author":"Saso","year":"2024","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.lanmic.2025.101219_bib19","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1473-3099(25)00072-6","article-title":"The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial","volume":"25","author":"Saso","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101219_bib20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/infdis\/jiy022","article-title":"Maternal vaccination with a monocomponent pertussis toxoid vaccine is sufficient to protect infants in a baboon model of whooping cough","volume":"217","author":"Kapil","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101219_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9258","article-title":"Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons","volume":"6","author":"Nguyen","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.lanmic.2025.101219_bib22","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1172\/JCI135020","article-title":"Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans","volume":"130","author":"Lin","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lanmic.2025.101219_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(22)02644-7","article-title":"Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus\u2013diphtheria\u2013acellular pertussis vaccine: a randomised, double-blind, phase 2b trial","volume":"401","author":"Keech","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2025.101219_bib24","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1172\/JCI121309","article-title":"Th1\/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters","volume":"128","author":"da Silva Antunes","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lanmic.2025.101219_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003264","article-title":"Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine","volume":"9","author":"Ross","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.lanmic.2025.101219_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1473-3099(18)30717-5","article-title":"Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial","volume":"19","author":"Barug","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101219_bib27","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-062664","article-title":"Maternal pertussis vaccination, infant immunization, and risk of pertussis","volume":"152","author":"Regan","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.lanmic.2025.101219_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapediatrics.2022.5689","article-title":"US infant pertussis incidence trends before and after implementation of the maternal tetanus, diphtheria, and pertussis vaccine","volume":"177","author":"Skoff","year":"2023","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.lanmic.2025.101219_bib29","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1016\/j.vaccine.2020.07.046","article-title":"Incidence and mortality of pertussis disease in infants <12 months of age following introduction of pertussis maternal universal mass vaccination in Bogot\u00e1, Colombia","volume":"38","author":"Carrasquilla","year":"2020","journal-title":"Vaccine"},{"issue":"suppl 4","key":"10.1016\/j.lanmic.2025.101219_bib30","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1093\/cid\/ciw559","article-title":"Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction","volume":"63","author":"Amirthalingam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101219_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijid.2014.03.556","article-title":"Sex differences in immune responses to vaccines","volume":"21","author":"Noho-Konteh","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101219_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231570","article-title":"A multi-country, multi-year, meta-analytic evaluation of the sex differences in age-specific pertussis incidence rates","volume":"15","author":"Peer","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101219_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/infdis\/jiad332","article-title":"Repeated Bordetella pertussis infections are required to reprogram acellular pertussis vaccine-primed host responses in the baboon model","volume":"229","author":"Kapil","year":"2024","journal-title":"J Infect Dis"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725001478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725001478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:56:49Z","timestamp":1790283409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524725001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666524725001478"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101219","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal immune responses to Bordetella pertussis in Gambian infants after maternal and primary vaccination: an immunological substudy of a single-centre, randomised, controlled, double-blind, phase 4 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101219"}}